Thermography monitors breast health using an infrared camera to capture high resolution images of temperature and vascular changes in the breasts. The temperature in tissue rises when infection, disease or a tumor is present. This temperature increase is the first change that takes place in cases of abnormal cellular function. Cancer cells grow and multiply at a rapid rate, so blood flow is higher in the areas near a growing tumor. Thermography detects inflammation through the increased skin temperature near these locations. The unique ability to alert a person of inflammation and abnormal cellular activities before it develops into cancer is the main benefit of thermography.
Early Detection and Intervention
A tumor starts off with inflammation and takes many years to grow.
Thermography gives you the chance to see inflammation and abnormalities up to 8-10 years before tumors can be detected by a mammogram, MRI, or ultrasound or felt by a physical exam.
With periodic thermography screening you have the ability to monitor abnormal tissue functions.
Thermography results gives you the chance to start simple lifestyle changes and treatment right away, in order to reverse inflammation and abnormal physiology, before a serious disease or cancer has the chance to develop.
Abnormalities can be corrected through diet, supplements and other lifestyle changes after only a few months.
Thermography is the most effective screening technology that can help prevent breast cancer and possibly end the breast cancer epidemic.
Inflammatory Breast Cancer
The results of this routine study led to the diagnosis of inflammatory carcinoma in the right breast. There were no clinical indications at this stage. (Thermography can show significant indicators several months before any of the clinical signs of inflammatory breast cancer, skin discoloration, swelling and pain). Inflammatory breast cancer cannot be detected by mammography and is most commonly seen in younger women, the prognosis is always poor. Early detection provides the best hope of survival.
A Review of Breast Thermography:
Over 30 years of research compiling over 800 studies in the index-medicus exist. What follows is a pertinent sample review of the research concerning the clinical application of diagnostic infrared imaging (thermography) for use in breast cancer screening. All the citations are taken from the index-medicus peer-reviewed research literature or medical textbooks. The authors are either PhD’s with their doctorate in a representative field, or physicians primarily in the specialties of oncology, radiology, gynecology, and internal medicine.The following list is a summary of the informational text that follows:
In 1982, the FDA approved breast thermography as an adjunctive diagnostic breast cancer screening procedure.
Breast thermography has undergone extensive research since the late 1950’s.
Over 800 peer-reviewed studies on breast thermography exist in the index-medicus literature.
In this database, well over 300,000 women have been included as study participants.
The numbers of participants in many studies are very large — 10K, 37K, 60K, 85K.
Some of these studies have followed patients up to 12 years.
Strict standardized interpretation protocols have been established for over 15 years.
Breast thermography has an average sensitivity and specificity of 90%.
An abnormal thermogram is 10 times more significant as a future risk indicator for breast cancer than a first order family history of the disease .
A persistent abnormal thermogram carries with it a 22x higher risk of future breast cancer. An abnormal infrared image is the single most important marker of high risk for developing breast cancer. Breast thermography has the ability to detect the first signs that a cancer may be forming up to 10 years before any other procedure can detect it.
Extensive clinical trials have shown that breast thermography significantly augments the long-term survival rates of its recipients by as much as 61%.
When used as part of a multimodal approach (clinical examination + mammography + thermography) 95% of early stage cancers will be detected.
